QUIDELORTHO CORP Investing Cash Flow
QUIDELORTHO CORP (QDEL) reported Investing Cash Flow of -$141.30 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-07
- QUIDELORTHO CORP net cash provided by (used in) investing activities for the quarter ending 2026-06-28 was -$107.30M.
- QUIDELORTHO CORP net cash provided by (used in) investing activities for the quarter ending 2026-03-29 was -$34.00M.
- QUIDELORTHO CORP net cash provided by (used in) investing activities for the quarter ending 2025-12-28 was -$49.60M.
- QUIDELORTHO CORP net cash provided by (used in) investing activities for the quarter ending 2025-09-28 was -$53.90M.
- QUIDELORTHO CORP net cash provided by (used in) investing activities for fiscal 2025 was -$192.70M.
- QUIDELORTHO CORP net cash provided by (used in) investing activities for fiscal 2024 was -$149.90M.
- QUIDELORTHO CORP net cash provided by (used in) investing activities for fiscal 2023 was -$187.60M.
- QUIDELORTHO CORP net cash provided by (used in) investing activities for fiscal 2023 was -$1.64B.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$107.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$141.30M 10-Q · filed 2026-08-07 | -$190.90M derived: sum of 3 quarters · filed 2026-08-07 | -$244.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | -$34.00M 10-Q · filed 2026-05-06 | -$83.60M derived: sum of 2 quarters · filed 2026-05-06 | -$137.50M derived: sum of 3 quarters · filed 2026-05-06 | -$170.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | -$49.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$103.50M derived: sum of 2 quarters · filed 2026-02-19 | -$136.50M derived: sum of 3 quarters · filed 2026-08-07 | -$192.70M 10-K · filed 2026-02-19 |
| 2025-09-28 | -$53.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$86.90M derived: sum of 2 quarters · filed 2026-08-07 | -$143.10M 10-Q · filed 2025-11-06 | -$181.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | -$33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$89.20M 10-Q · filed 2026-08-07 | -$127.10M derived: sum of 3 quarters · filed 2026-08-07 | -$183.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | -$56.20M 10-Q · filed 2026-05-06 | -$94.10M derived: sum of 2 quarters · filed 2026-05-06 | -$150.60M derived: sum of 3 quarters · filed 2026-05-06 | -$185.90M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | -$37.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$94.40M derived: sum of 2 quarters · filed 2026-02-19 | -$129.70M derived: sum of 3 quarters · filed 2026-02-19 | -$149.90M 10-K · filed 2026-02-19 |
| 2024-09-29 | -$56.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$91.80M derived: sum of 2 quarters · filed 2025-11-06 | -$112.00M 10-Q · filed 2025-11-06 | -$167.10M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$35.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$55.50M 10-Q · filed 2025-08-06 | -$110.60M derived: sum of 3 quarters · filed 2026-02-19 | -$131.90M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$20.20M 10-Q · filed 2025-05-08 | -$75.30M derived: sum of 2 quarters · filed 2026-02-19 | -$96.60M derived: sum of 3 quarters · filed 2026-02-19 | -$138.90M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$55.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$76.40M derived: sum of 2 quarters · filed 2026-02-19 | -$118.70M derived: sum of 3 quarters · filed 2026-02-19 | -$187.60M 10-K · filed 2026-02-19 |
| 2023-10-01 | -$21.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$63.60M derived: sum of 2 quarters · filed 2024-11-08 | -$132.50M 10-Q · filed 2024-11-08 | -$191.80M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$42.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$111.20M 10-Q · filed 2024-08-01 | -$170.50M derived: sum of 3 quarters · filed 2025-02-27 | -$200.30M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | -$68.90M 10-Q · filed 2024-05-09 | -$128.20M derived: sum of 2 quarters · filed 2025-02-27 | -$158.00M derived: sum of 3 quarters · filed 2025-02-27 | -$1.69B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | -$59.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$89.10M derived: sum of 2 quarters · filed 2025-02-27 | -$1.62B derived: sum of 3 quarters · filed 2025-02-27 | -$1.64B 10-K · filed 2025-02-27 |
| 2022-10-02 | -$29.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.56B derived: sum of 2 quarters · filed 2023-11-02 | -$1.58B 10-Q · filed 2023-11-02 | -$1.68B derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | -$1.53B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.56B 10-Q · filed 2023-08-09 | -$1.65B derived: sum of 3 quarters · filed 2024-08-01 | -$1.74B derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | -$24.70M 10-Q · filed 2023-05-04 | -$120.70M derived: sum of 2 quarters · filed 2024-08-01 | -$213.90M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | -$96.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | -$189.20M derived: sum of 2 quarters · filed 2024-08-01 | -$319.50M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | -$93.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$223.50M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | -$130.30M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | -$63.30M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |